• Slider 1
  • Slider 1
  • Slider 1
  • Slider 1
  • Slider 1
  • Slider 1
  • Slider 1
  • Slider 1

Mission

The Ludwig Boltzmann Institute of Osteology (LBIO) was founded in 1991 based on a partnership agreement between Austrian Workers' Compensation Board (AUVA), Vienna Health Insurance Fund (WGKK) and Ludwig Boltzmann Gesellschaft (LBG) at the Hanusch Hospital and the Trauma Centre Meidling, with Klaus Klaushofer, MD, serving as the Scientific and Administrative Head. A board oversees the scientific and administrative activities of the LBIO with board members of the partner institutions (AUVA, WGKK, LBG). Special emphasis was placed on the organization and performance of multidisciplinary basic and clinical research in bone and mineral metabolism with the main focus on translational medicine. Thus, the LBIO serves as the scientific core center within a multidisciplinary clinical network located at the two hospitals targeting diagnosis and treatment of bone and joint diseases.

Its mission is to achieve the highest level of scientific excellence through basic and clinical research, as well as the training of young scientists in clinical and experimental Osteology and the gender-neutral development of their careers.

LBIO’s goal is the improvement of patient care. Towards this goal, the study of bone is undertaken at all hierarchical levels through a combination of techniques, unique worldwide.

The aim is the elucidation of the mechanisms underlying the basic function of bone, and musculoskeletal diseases, leading to the discovery and development of effective strategies for diagnosis, prevention, and treatment.

To achieve the stated goal, LBIO basic scientists and clinicians in tandem with scientists of the Department of Biomaterials of the Max Planck Institute of Colloids and Interfaces, Potsdam, Germany, as well as national and international collaborators and industry, are utilizing in partnerships the globally unparalleled LBIO expertise and available combination of analytical approaches to study bone at all hierarchical levels. The existing combination of instrumental capabilities allows analyses to be performed from a clinical, cell & molecular biology, physical chemical, and material science perspective.